In this conference report we discuss our highlights from the 13th Workshop on Recent Issues in Bioanalysis (WRIB; New Orleans, USA; 1–4 April).
As part of our mini-Spotlight on cell and gene therapies, we carried out a survey to gain an insight into the trends, challenges and developments associated with these fields – find out the results in this informative infographic.
Find out more about the challenges associated with gene therapy and what the future may hold for the field in this interview with Hugh Davis (Frontage Laboratories; PA, USA).
An author’s perspective: George Jaskiw on quantification of phenolic acid metabolites in humans by LC–MS
We talk to George Jaskiw about his work on quantification of phenolic acid metabolites in humans by LC–MS in this interview as part of our author’s perspective series.
With the reality of Brexit already impacting the UK’s clinical trials environment, Zamas Lam (QPS; DE, USA) discusses the effect this will have on bioanalytical research, and suggests 10 questions to ask when relocating UK-based preclinical and bioanalysis research projects.
In this installment of Robert MacNeill’s (Envigo) column, Robert discusses methodologies for small lipids, and why these can be a particularly challenging area of biologics.
As part of our mini-Spotlight on proteomics, we carried out a survey to gain an insight into the trends, challenges and developments associated with proteomics R&D – find out the results in this informative infographic.
To kick-start this special focus, we wanted to hear your thoughts on the topic – complete our short survey on cellular and gene therapy to be the first to receive our informative infographic collated from the survey results.
We look at some of the highlights of our Twitter chat (#TalkProteomics), where we questioned panelists John Wilson, Ben Orsburn, Matthias Trost and Eduardo Chicano Gálvez about all things proteomics – from mass spectrometry to drug discovery.
We are revisiting this area to explore how the oligonucleotide field has actually developed and provide a critical review of where we are now.